QQQ

DIA

SPY

TLT

GLD

BTC/USD

QQQ

DIA

SPY

TLT

GLD

BTC/USD

Cannabis Capital Conference

Several Reasons Why Not To Miss Benzinga's Cannabis Capital Conference In Chicago This Coming September

Several Reasons Why Not To Miss Benzinga's Cannabis Capital Conference In Chicago This Coming September

The first reason of all is that the Benzinga Cannabis Capital Conference is being held in Chicago on Sept 13-14, which means several things including the Art Institute of Chicago.

Jun 29, 2022, 5:28 PM

EXCLUSIVE: Why Should Cannabis Brands Focus On Social Equity? Thoughts On 4/20 And Peter Tosh Day

EXCLUSIVE: Why Should Cannabis Brands Focus On Social Equity? Thoughts On 4/20 And Peter Tosh Day

The cannabis industry was built on the backs of people who have been disproportionately impacted by the war on drugs, people and communities of color, said Roz McCarthy, founder and CEO of Minorities for Medical Marijuana, during a panel discussion at the Benzinga Canna

Apr 20, 2022, 3:31 PM

EXCLUSIVE: Sundial CEO Says Support Of Retail Investors Key To Turnaround

EXCLUSIVE: Sundial CEO Says Support Of Retail Investors Key To Turnaround

The saturation of the Canadian cannabis market and the ways that retail traders are helping Sundial’s turnaround were among the topics Sundial Growers Inc (NASDAQ: SNDL) CEO Zach George discussed during the last iteration of the Ben

Oct 7, 2021, 11:05 AM

Charlotte's Web CEO Says Road To Federal Cannabis Legalization Must Start With CBD Regulation

Charlotte's Web CEO Says Road To Federal Cannabis Legalization Must Start With CBD Regulation

Charlotte's Web Holdings Inc. (OTCQX: CWBHF) CEO Deanie Elsner discussed the hemp CBD extract company’s development, future plans and mission during the last iteration of the Benzinga Cannabis Capital Conference

Oct 7, 2021, 10:59 AM

EXCLUSIVE: MagicMed CEO On Psychedelics Company's 'Secret Sauce,' M&A Deal With Enveric Biosciences

EXCLUSIVE: MagicMed CEO On Psychedelics Company's 'Secret Sauce,' M&A Deal With Enveric Biosciences

MagicMed's focus is on creating new molecules based on psychedelics, said CEO Dr. Joseph Tucker — but with better attributes.

Jun 4, 2021, 4:46 PM